EUVIMEDEUVIMED entdecken
Crossref

Response to oral steroids for sudden sensorineural hearing loss: considerations of age, time to treatment, and degree of hearing loss

Erin Harvey, Grace Callan, Neil Osafo, David Friedland, Michael S Harris, Jazzmyne Adams, Kristen Osinski, Ling Tong, Jake Luo

Audiology and Neurotology · 2025

DOI: 10.1159/000545672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Audiology and Neurotology, 2025. Verfasst von Erin Harvey und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Hearing Loss, Sudden, Hearing Loss, Sensorineural, Glucocorticoids, Time-to-Treatment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Compare outcomes of oral steroids (OS) to intratympanic (IT) steroids for treatment of idiopathic sudden sensorineural hearing loss (ISSNHL) in a retrospective cohort study at a tertiary academic center.

Methods

Patients diagnosed with ISSNHL receiving at least one course of OS between January 2009 and February 2022 were reviewed. OS patients were compared to a previously reported cohort of 74 patients who underwent IT treatment.

Interventions

OS or IT steroid therapy for ISSNHL. Full, partial or no recovery rates of hearing thresholds stratified by modality of treatment, age, degree of hearing loss, and time to initiation of treatment were measured.

Results

There were 96 patients treated with OS and 74 patients treated with IT steroid. Full recovery was more frequent in patients who underwent oral steroid therapy (43.8%) compared to IT therapy (25.68%, p=0.017). For patients under 40 years old, full recovery rates were similar between OS (60.0%) and IT (61.5%). In patients over 40 years old, however, full recovery was seen in 40.7% of patients on OS and 18% for IT. Further, while those over 65 years had the worst rates of full recovery to IT steroid (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hearing Loss, SuddenHearing Loss, SensorineuralGlucocorticoidsTime-to-TreatmentHumansFemaleMaleRetrospective StudiesMiddle AgedAdultAdministration, OralAge FactorsAgedInjection, IntratympanicTreatment OutcomeYoung Adult

Stichwörter der Autor:innen

Intratympanic steroidOutcomesSteroidsSudden hearing loss

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Department of Otolaryngology, University of Missouri, Columbia, Missouri, USA.
  • Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, USA, dfriedland@mcw.edu.
  • Clinical and Translational Science Institute Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Department of Health Informatics and Administration, University of Wisconsin - Milwaukee, Milwaukee, Wisconsin, USA.

Zitieren

APA

Harvey, E., Callan, G., Osafo, N., Friedland, D., Harris, M. S., Adams, J., Osinski, K., Tong, L., & Luo, J. (2025). Response to oral steroids for sudden sensorineural hearing loss: considerations of age, time to treatment, and degree of hearing loss. Audiology and Neurotology. https://doi.org/10.1159/000545672

Vancouver

Harvey E, Callan G, Osafo N, Friedland D, Harris MS, Adams J, et al. Response to oral steroids for sudden sensorineural hearing loss: considerations of age, time to treatment, and degree of hearing loss. Audiology and Neurotology. 2025. doi:10.1159/000545672

BibTeX
@article{Harvey2025,
  author = {Harvey, Erin and Callan, Grace and Osafo, Neil and Friedland, David and Harris, Michael S and Adams, Jazzmyne and Osinski, Kristen and Tong, Ling and Luo, Jake},
  title = {Response to oral steroids for sudden sensorineural hearing loss: considerations of age, time to treatment, and degree of hearing loss},
  journal = {Audiology and Neurotology},
  year = {2025},
  doi = {10.1159/000545672}
}
Kostenlos starten →